Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Leading the Way at ESC 2024

Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...

Medscape Education

- PMLiVE

WHO and CEPI call for broader research strategy to prepare for future pandemics

They have highlighted the importance of expanding research to entire families of pathogens

- PMLiVE

NewAmsterdam shares positive phase 3 results for CETP inhibitor obicetrapib in HeFH

Heterozygous familial hypercholesterolaemia affects approximately one in 250 people globally

- PMLiVE

FDA grants accelerated approval to Adaptimmune’s Tecelra for synovial sarcoma

Tecelra is now the first engineered cell therapy for a solid tumour cancer in the US

Rainbow colours inside Cuttsy+Cuttsy branded shapes

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Cuttsy + Cuttsy

- PMLiVE

Uniting Communities for Rare Disease Clinical Trial Success

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

Innovative Trials

- PMLiVE

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...

Innovative Trials

- PMLiVE

Solving your biggest patient recruitment and retention challenges

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...

Innovative Trials

- PMLiVE

Innovative Trials Announces New Charity Partnerships

Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year

Innovative Trials

- PMLiVE

GSK’s Jemperli combination approved by FDA for expanded endometrial cancer use

Approximately 417,000 new cases of endometrial cancer are reported globally every year

- PMLiVE

Lancet Commission report identifies two new modifiable dementia risk factors

The new risk factors identified are untreated vision loss and high low-density lipoprotein

- PMLiVE

Sanofi and British Transplant Games collaborate to raise awareness of graft versus host disease

The games will see over 1,000 transplant recipients and donors compete in over 25 sporting events

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links